CVE-2017-7917

Description

A Cross-Site Request Forgery issue was discovered in Moxa OnCell G3110-HSPA Version 1.3 build 15082117 and previous versions, OnCell G3110-HSDPA Version 1.2 Build 09123015 and previous versions, OnCell G3150-HSDPA Version 1.4 Build 11051315 and previous versions, OnCell 5104-HSDPA, OnCell 5104-HSPA, and OnCell 5004-HSPA. The application does not sufficiently verify if a request was intentionally provided by the user who submitted the request, which could allow an attacker to modify the configuration of the device.

Category

8.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.10%
Third-Party Advisory us-cert.gov
Affected: n/a Moxa OnCell
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSA-17-143-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2017-7917?
CVE-2017-7917 has been scored as a high severity vulnerability.
How to fix CVE-2017-7917?
To fix CVE-2017-7917, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-7917 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-7917 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-7917?
CVE-2017-7917 affects n/a Moxa OnCell.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.